North Miami Beach, FLORIDA2 Active Studies

Chronic Spontaneous Urticaria Clinical Trials in North Miami Beach, FLORIDA

Find 2 actively recruiting chronic spontaneous urticaria clinical trials in North Miami Beach, FLORIDA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
475
Enrolling

Recruiting Chronic Spontaneous Urticaria Studies in North Miami Beach

About Chronic Spontaneous Urticaria Clinical Trials in North Miami Beach

Chronic spontaneous urticaria involves the recurrence of hives and/or angioedema for more than six weeks without an identifiable external trigger. It significantly impacts quality of life. Treatment includes second-generation antihistamines and biologics like omalizumab.

There are currently 2 chronic spontaneous urticaria clinical trials recruiting participants in North Miami Beach, FLORIDA. These studies are seeking a combined 475 participants. Research is being sponsored by Novartis Pharmaceuticals, InflaRx GmbH. Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Spontaneous Urticaria Clinical Trials in North Miami Beach — FAQ

Are there chronic spontaneous urticaria clinical trials in North Miami Beach?

Yes, there are 2 chronic spontaneous urticaria clinical trials currently recruiting in North Miami Beach, FLORIDA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in North Miami Beach?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the North Miami Beach research site will contact you about next steps.

Are clinical trials in North Miami Beach free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many North Miami Beach studies also compensate for your time and travel.

What chronic spontaneous urticaria treatments are being tested?

The 2 active trials in North Miami Beach are testing new therapies including novel drugs, biologics, and treatment approaches for chronic spontaneous urticaria.

Data updated March 2, 2026 from ClinicalTrials.gov